It’s time for another edition of Reading Roundup featuring the top blog posts of August 2017. Start off your week by catching up on what the pharmaceutical industry was reading in August.
Performance and Validation of Ozone Generation for Pharmaceutical Water Systems – Part 1
This article was originally published in the July-August 2017 issue of Pharmaceutical Engineering® magazine. Despite the advantages of ozone technology as a powerful commercially available oxidant and disinfectant, this technology has not been adopted broadly by the pharmaceutical industry. This article contains the rationale for applying ozone technology in a packaged system.
Member Spotlight: Maria Rosario Barangan
"I believe that the Pharmaceutical Industry will continue to face bigger challenges. On a global scale, as more countries push for Universal Health Care, the demand for good quality medicines at reasonable prices will continue to increase."
Looking Ahead - 2017 Pharmaceutical Industry Trends
This article was published in the January-February 2017 edition of Pharmaceutical Engineering® magazine. What does 2017 hold in store for the pharmaceutical industry? What will be the most important pharmaceutical industry drivers, its innovations, if any? What indeed!
Brexit Update: A Substantial Prize in the EMA Relocation Bid
With the Brexit referendum resulting in the United Kingdom (UK)’s decision to leave the European Union (EU), the European Medicines Agency (EMA), currently located at Canary Wharf in London, will need to find a new home. At an EU Summit in Brussels 22 June 2017, the European Council adopted a procedure on how the EU will decide where to relocate the agency. It will culminate in a vote in November by all 27 member states, not including the UK.
Why Is Process Validation an Essential Success Factor in Biotechnology Manufacturing?
To deliver a consistent and reliable final product, process validation is a crucial concept to understand. The three-stage paradigm covers the entire product lifecycle to manufacture a product by developing control strategies to regulate all attributes of product quality.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
